Abstract

Caveolin-1 (Cav-1) is an important structural protein of caveolae and plays an oncogene-like role by influencing protein glycosylation in hepatocellular carcinoma (HCC) cells. However, the mechanism by which Cav-1 promotes invasion and metastasis capacity has not been completely clarified. In this study, we demonstrate that Pofut1 is a fucosyltransferase induced by Cav-1. Mouse Hepa1-6 HCC cells lacking Cav-1 expression exhibited low transcription levels of Pofut1, whereas strong Pofut1 expression was found in high-metastasis-potential Hca-F cells with high levels of Cav-1. Cav-1 activated MAPK signaling and promoted phosphorylation of the transcription factors CREB, Sp1, HNF4A and c-Myc, which bound to the Pofut1 promoter region to induce its transcription. As Notch signaling receptors can be modified with O-fucose by Pofut1, we further showed that Cav-1-induced upregulation of Pofut1 expression activated the Notch pathway and thus enhanced invasion and metastasis by mouse HCC cells in vitro and in vivo. Collectively, our findings reveal a novel mechanism by which Cav-1 promotes tumor metastasis by upregulating expression of Pofut1, suggesting that Cav-1 may function as a new biomarker for HCC.

Highlights

  • Caveolin-1 (Cav-1), a major structural protein of caveolae, has been implicated in many cellular processes, including lipid transport, signal transduction, and tumor progression

  • We demonstrate that Cav-1 upregulates expression of Pofut[1] by activating the mitogen-activated protein kinase (MAPK) pathway to increase the phosphorylation levels of downstream transcription factors that bind to the promoter region of Pofut[1]

  • Cav-1 is an essential structural and functional component of caveolae that is widely expressed in eukaryotes; this protein is mainly distributed in terminally differentiated cells, such as myocytes, endothelial cells, epithelial cells, and fibroblasts

Read more

Summary

Introduction

Caveolin-1 (Cav-1), a major structural protein of caveolae, has been implicated in many cellular processes, including lipid transport, signal transduction, and tumor progression. There is a growing body of evidence that Cav-1 can regulate protein glycosylation[4,5,6]. Previous studies performed by our laboratory showed that Cav-1 promotes lymphatic metastasis of mouse hepatocellular carcinoma (HCC) cells by inducing CD147 glycosylation[8,9]. Cav-1 can promote sialylation of HCC cells by enhancing the expression of glycosyltransferase ST6Gal-1, increasing the adhesion ability of these cells[10]. The above evidence indicates that Cav-1 exerts an oncogene-like effect in HCC by affecting glycosylation levels, glycosylation-related protein localization, and glycosyltransferase expression. Overexpression of certain fucosyltransferases (FUTs) in tumor cells leads to an increased level of fucosylation, resulting in abnormal cell proliferation, the epithelial–mesenchymal

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.